Alzheimer’s disease research studies need more participants and broader diversity. A panel of experts recently published new recommendations for enhancing recruitment of participants for Alzheimer’s...
At the Alzheimer’s Association International Conference in August 2022, the precedent-setting Alzheimer’s Prevention Initiative study based in Colombia reported the study drug did not slow cognitive...
Beginning in July, several Alzheimer’s disease trials will release their study results. Will this be the year a potential treatment or prevention therapy is discovered? Dr. Alireza Atri from the...
Recent studies suggest a link between Alzheimer’s disease and autism spectrum disorder. Scientists are asking the question: As children diagnosed with autism age into adulthood, how will their...
In its annual report, the Global Council on Brain Health and AARP brought together experts from around the world to discuss how society can do more to promote activities to support healthy brains as...
This year the Alzheimer’s Prevention Registry turns 10! We’ve achieved many milestones over the past decade thanks to our members who continue to express interest in Alzheimer’s-focused...
Family caregivers are the backbone of long-term care for people with Alzheimer’s disease and other dementias. Research studies are now focused on how to support caregivers throughout the course of a...
Approximately 75% of adults with Down syndrome develop Alzheimer’s disease by the age of 65. Researchers are now creating more studies to explore the link between the two and plan to bring the latest...
New drugs and medical devices are tested for safety and effectiveness in several phases of clinical trials. But how exactly does a clinical trial work? And what is the difference between Phase I and...
Thank you for your continued support of our mission to end Alzheimer’s disease before losing another generation. As 2021 comes to a close, we are excited about the many new opportunities we foresee...
